These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 30117406)

  • 21. Long-term Results of a Comparative PET/CT and PET/MRI Study of 11C-Acetate and 18F-Fluorocholine for Restaging of Early Recurrent Prostate Cancer.
    Lamanna G; Tabouret-Viaud C; Rager O; Jorcano S; Vees HJ; Seimbille Y; Zaidi H; Ratib O; Buchegger F; Miralbell R; Zilli T; Garibotto V
    Clin Nucl Med; 2017 May; 42(5):e242-e246. PubMed ID: 28240662
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic value of metabolic parameters and clinical impact of ¹⁸F-fluorocholine PET/CT in biochemical recurrent prostate cancer.
    Colombié M; Campion L; Bailly C; Rusu D; Rousseau T; Mathieu C; Ferrer L; Rousseau N; Kraeber-Bodéré F; Rousseau C
    Eur J Nucl Med Mol Imaging; 2015 Nov; 42(12):1784-93. PubMed ID: 26194716
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fluorocholine PET/CT predicts skeletal progression, skeletal event and cancer specific survival in patients with biochemical relapse for prostate cancer.
    Zattoni F; Agostini E; Cattaneo F; Maruzzo M; Basso U; Zattoni F; Evangelista L
    Clin Imaging; 2017; 43():110-116. PubMed ID: 28278446
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 18F choline PET/CT in the preoperative staging of prostate cancer in patients with intermediate or high risk of extracapsular disease: a prospective study of 130 patients.
    Beheshti M; Imamovic L; Broinger G; Vali R; Waldenberger P; Stoiber F; Nader M; Gruy B; Janetschek G; Langsteger W
    Radiology; 2010 Mar; 254(3):925-33. PubMed ID: 20177103
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [18F]fluoromethylcholine (FCH) positron emission tomography/computed tomography (PET/CT) for lymph node staging of prostate cancer: a prospective study of 210 patients.
    Poulsen MH; Bouchelouche K; Høilund-Carlsen PF; Petersen H; Gerke O; Steffansen SI; Marcussen N; Svolgaard N; Vach W; Geertsen U; Walter S
    BJU Int; 2012 Dec; 110(11):1666-71. PubMed ID: 22520686
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 18F-Fluorocholine PET/CT Finding of a Vertebral Hemangioma.
    Savelli G; Perotti V; Rosso E; Pizzocaro C; Magnaldi S
    Clin Nucl Med; 2016 Aug; 41(8):e390-1. PubMed ID: 27124683
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Volumetric analysis of 18F-FDG PET in glioblastoma multiforme: prognostic information and possible role in definition of target volumes in radiation dose escalation.
    Tralins KS; Douglas JG; Stelzer KJ; Mankoff DA; Silbergeld DL; Rostomily RC; Hummel S; Scharnhorst J; Krohn KA; Spence AM
    J Nucl Med; 2002 Dec; 43(12):1667-73. PubMed ID: 12468518
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A pilot comparison of 18F-fluorodeoxyglucose and 18F-fluorocholine PET/CT to predict early recurrence of unifocal hepatocellular carcinoma after surgical resection.
    Fartoux L; Balogova S; Nataf V; Kerrou K; Huchet V; Rosmorduc O; Talbot JN
    Nucl Med Commun; 2012 Jul; 33(7):757-65. PubMed ID: 22504293
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 18F-PSMA 1007 Brain PET/CT Imaging in Glioma Recurrence.
    Marafi F; Sasikumar A; Fathallah W; Esmail A
    Clin Nucl Med; 2020 Jan; 45(1):e61-e62. PubMed ID: 31162269
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Detection of bronchioloalveolar cancer by means of PET/CT and 18F-fluorocholine, and comparison with 18F-fluorodeoxyglucose.
    Balogova S; Huchet V; Kerrou K; Nataf V; Gutman F; Antoine M; Ruppert AM; Prignon A; Lavolée A; Montravers F; Mayaud C; Cadranel J; Talbot JN
    Nucl Med Commun; 2010 May; 31(5):389-97. PubMed ID: 20145579
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dual-phase (18)F-fluorocholine PET/CT to detect locoregional recurrence of prostate cancer: comparison between each time point of imaging and a summation scan.
    Tong AK; Zhang ZX; Zaheer S; Yan XS
    Clin Imaging; 2016; 40(3):486-91. PubMed ID: 27133692
    [TBL] [Abstract][Full Text] [Related]  

  • 32. PET/CT in patients with hepatocellular carcinoma using [(18)F]fluorocholine: preliminary comparison with [(18)F]FDG PET/CT.
    Talbot JN; Gutman F; Fartoux L; Grange JD; Ganne N; Kerrou K; Grahek D; Montravers F; Poupon R; Rosmorduc O
    Eur J Nucl Med Mol Imaging; 2006 Nov; 33(11):1285-9. PubMed ID: 16802155
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of 18F-choline and 11C-choline as contrast agents in positron emission tomography imaging-guided stereotactic biopsy sampling of gliomas.
    Hara T; Kondo T; Hara T; Kosaka N
    J Neurosurg; 2003 Sep; 99(3):474-9. PubMed ID: 12959432
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Uptake of 18F-fluorocholine, 18F-fluoro-ethyl-L: -tyrosine and 18F-fluoro-2-deoxyglucose in F98 gliomas in the rat.
    Spaeth N; Wyss MT; Pahnke J; Biollaz G; Lutz A; Goepfert K; Westera G; Treyer V; Weber B; Buck A
    Eur J Nucl Med Mol Imaging; 2006 Jun; 33(6):673-82. PubMed ID: 16538503
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fluorine-18 fluorocholine PET-CT localizes hyperparathyroidism in patients with inconclusive conventional imaging: a multicenter study from the Netherlands.
    Kluijfhout WP; Vorselaars WM; van den Berk SA; Vriens MR; Borel Rinkes IH; Valk GD; van Dalen T; de Klerk JM; de Keizer B
    Nucl Med Commun; 2016 Dec; 37(12):1246-1252. PubMed ID: 27612033
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The PET/CT with 18F-fluorocholine in the diagnosis of gliomatosis cerebri type 2].
    Niccoli-Asabella A; Notaristefano A; Garribba MG; Rubini D; Ferrari C; Rubini G
    Recenti Prog Med; 2013 Feb; 104(2):73-5. PubMed ID: 23535962
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Incidental possible diagnosis by 18F-fluorocholine PET/CT of Meckel's diverticulum and potential pitfalls.
    Khor LK; Loi HY; Sinha AK; Lu SJ
    Hell J Nucl Med; 2015; 18(2):157-9. PubMed ID: 26187217
    [TBL] [Abstract][Full Text] [Related]  

  • 38. F18-choline PET/CT guided surgery in primary hyperparathyroidism when ultrasound and MIBI SPECT/CT are negative or inconclusive: the APACH1 study.
    Quak E; Blanchard D; Houdu B; Le Roux Y; Ciappuccini R; Lireux B; de Raucourt D; Grellard JM; Licaj I; Bardet S; Reznik Y; Clarisse B; Aide N
    Eur J Nucl Med Mol Imaging; 2018 Apr; 45(4):658-666. PubMed ID: 29270788
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diagnostic performances of [18F]fluorocholine positron emission tomography in brain tumors.
    Sollini M; Sghedoni R; Erba PA; Cavuto S; Froio A; De Berti G; Pisanello A; Fraternali A; Iori M; Iaccarino C; Iori M; Asti M; Filice A; Versari A
    Q J Nucl Med Mol Imaging; 2018 Jun; 62(2):209-219. PubMed ID: 26329494
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Early and Delayed 18F-FCH PET/CT Imaging in Parathyroid Adenomas.
    Vellani C; Hodolič M; Chytiris S; Trifirò G; Rubello D; Colletti PM
    Clin Nucl Med; 2017 Feb; 42(2):143-144. PubMed ID: 27941372
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.